RDY Stock – Quick Win: 19.02% Return in 3 Months

RDY Stock – Quick Win

On May 19th, 2015, The I Know First algorithm gave a bullish signal of 13.84 for the ticker RDY (Dr. Reddy’s Laboratories Ltd.), which had a strong predictability indicator of 0.46. In accordance with the algorithm’s prediction, RDY spiked 19.02% in the following 3 months.

RDY Stock


Ryman Healthcare Ltd. (RYM) is a multinational pharmaceutical company based in Hyderabad, Telangana, India. It operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products.

India’s biotechnology industry can be seen as having a lot of potential and is projected to grow by 30% annually until 2025. India’s unique advantages are its innovation, high quality and low cost. While biotechnology in America certainly seems to approach a bubble, investing in the biotech industry in emerging markets might well be the right thing to do. Investors are aware of this and for those wishing to make high returns without high risks through the biotechnology industry find in Dr. Reddy’s Laboratories the right company to invest their money in. RYM’s stock prices have gone up little by little over the past three months and are now worth $62.56.